News | Focused Ultrasound Therapy | February 16, 2021

Insightec plans to expand in Latin America through a partnership with Strattner

Insightec plans to expand in Latin America through a partnership with Strattner

February 16, 2021 — Insightec, a global healthcare company focused on creating the next generation of patient care, announced it received market approval by the Brazilian Health Regulatory Agency ANVISA (Agência Nacional de Vigilância Sanitária), and is partnering with Strattner to bring focused ultrasound to the Brazilian market.

This approval of the Exablate 4000 (Exablate Neuro) platform, which uses MR-guided focused ultrasound to precisely ablate tissue deep within the brain without incisions, will enable treatment for essential tremor and tremor-dominant Parkinson's Disease that has not responded to medications and neuropathic pain. 

Insightec is working with Strattner, a leading distributor of equipment for minimally invasive and robotic surgery, to reach leading medical centers and help advance adoption of focused ultrasound in the Brazilian market.  

"Leading neuroscience departments at medical centers around the globe recognize the value of adopting Focused Ultrasound as a treatment option for patient care. We are excited by the opportunities of expansion into Latin America," commented Maurice R. Ferré M.D., Insightec CEO and Chair of the Board of Directors.

Nearly 60 leading medical centers globally treat patients with debilitating hand tremor using Exablate Neuro. Performed in a single session in an MRI suite, many patients experience immediate tremor relief with minimal side effects.

"There are millions of Brazilians suffering from Essential Tremor or Tremor-dominant Parkinson's Disease and Exablate Neuro Focused Ultrasound has the potential to change their lives, through an incisionless procedure," said Felipe Strattner, Head of Strategy at Strattner. "We are eager to bring this transformational technology to medical centers across Brazil and help drive medicine forward in our country."

Exablate Neuro is the first and only focused ultrasound device approved by the U.S. Food and Drug Administration to treat medication-refractory Essential Tremor and Tremor-dominant Parkinson's Disease.

"Brazil represents a key strategic market in Latin America and this approval strongly positions Focused Ultrasound for future growth in the region," said J. Michael Quijano, Head of Strategic Partnerships & Business Development, Americas at Insightec.

For more information: www.insightec.com


Related Content

News | Point-of-Care Ultrasound (POCUS)

June 17, 2025 — Royal Philips has announced the global launch of the Flash Ultrasound System 5100 POC — a new point-of ...

Time June 19, 2025
arrow
News | Lung Imaging

June 18, 2025 — Exo recently announced that now included on its Exo Iris is the first ever FDA 510(k) cleared AI for ...

Time June 18, 2025
arrow
News | Imaging Software Development

June 12, 2025 — GE HealthCare has announced the combination of GE HealthCare’s proprietary features and algorithms with ...

Time June 12, 2025
arrow
News | Radiology Business

The issue of sustainability in healthcare has gained increasing focus over the past several years. During a 2022 plenary ...

Time May 06, 2025
arrow
News | Artificial Intelligence

April 16, 2025 — An artificial intelligence (AI) program trained to review images from a common medical test can detect ...

Time April 16, 2025
arrow
News | Ultrasound Women's Health

April 11, 2025 — Contrast-enhanced ultrasound (CEUS) is a safe and accurate diagnostic imaging option for pregnant women ...

Time April 11, 2025
arrow
News | Pediatric Imaging

April 10, 2025 — Cincinnati Children’s and GE HealthCare will form a strategic research program focused on driving ...

Time April 10, 2025
arrow
News | Focused Ultrasound Therapy

March 31, 2025 — Neuropathic pain affects up to 10 percent of the global population and can be challenging to manage ...

Time April 02, 2025
arrow
News | Breast Imaging

March 20, 2025 — GE HealthCare has launched Invenia Automated Breast Ultrasound (ABUS) Premium, the latest 3D ultrasound ...

Time March 21, 2025
arrow
News | X-Ray

March 18, 2025 — GE HealthCare recently announced a collaboration with NVIDIA expanding the existing relationship ...

Time March 19, 2025
arrow
Subscribe Now